ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 271 filers reported holding ALKERMES PLC in Q3 2022. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,037,503 | +536.0% | 72,742 | +610.7% | 0.26% | +484.1% |
| Q2 2023 | $320,356 | -81.2% | 10,235 | -83.0% | 0.04% | -80.9% |
| Q1 2023 | $1,700,139 | -54.0% | 60,310 | -57.3% | 0.23% | -61.5% |
| Q4 2022 | $3,693,763 | +27.3% | 141,361 | +8.8% | 0.60% | +36.2% |
| Q3 2022 | $2,901,000 | -46.8% | 129,899 | -29.0% | 0.44% | -8.7% |
| Q2 2022 | $5,450,000 | +22.8% | 182,946 | +8.5% | 0.48% | +25.9% |
| Q1 2022 | $4,437,000 | -5.6% | 168,637 | -16.5% | 0.38% | +6.7% |
| Q4 2021 | $4,699,000 | +1.0% | 202,003 | +34.0% | 0.36% | +7.2% |
| Q3 2021 | $4,651,000 | -19.5% | 150,800 | -36.0% | 0.33% | -12.6% |
| Q2 2021 | $5,777,000 | +63.7% | 235,600 | +24.7% | 0.38% | +50.4% |
| Q1 2021 | $3,528,000 | +8.0% | 188,860 | +15.3% | 0.25% | +14.9% |
| Q4 2020 | $3,268,000 | -5.5% | 163,828 | -21.5% | 0.22% | -3.1% |
| Q3 2020 | $3,457,000 | -17.4% | 208,600 | -3.3% | 0.23% | -20.0% |
| Q2 2020 | $4,186,000 | -15.1% | 215,731 | -36.9% | 0.28% | -26.9% |
| Q1 2020 | $4,930,000 | +3.7% | 341,900 | +46.7% | 0.39% | +33.1% |
| Q4 2019 | $4,754,000 | +16.2% | 233,019 | +11.1% | 0.29% | +20.6% |
| Q3 2019 | $4,092,000 | +53.7% | 209,752 | +77.6% | 0.24% | +54.8% |
| Q2 2019 | $2,662,000 | -20.6% | 118,100 | +28.6% | 0.16% | -16.9% |
| Q1 2019 | $3,351,000 | -14.9% | 91,847 | -31.2% | 0.19% | -14.1% |
| Q4 2018 | $3,940,000 | +11.5% | 133,500 | +60.3% | 0.22% | +49.7% |
| Q3 2018 | $3,534,000 | -31.4% | 83,269 | -33.5% | 0.15% | -25.0% |
| Q2 2018 | $5,153,000 | +382.9% | 125,200 | +615.4% | 0.20% | +653.8% |
| Q1 2015 | $1,067,000 | +4.1% | 17,500 | 0.0% | 0.03% | -74.5% |
| Q4 2014 | $1,025,000 | -39.3% | 17,500 | -55.6% | 0.10% | +131.8% |
| Q3 2014 | $1,689,000 | +182.0% | 39,401 | +231.1% | 0.04% | +175.0% |
| Q2 2014 | $599,000 | +14.1% | 11,900 | 0.0% | 0.02% | +23.1% |
| Q1 2014 | $525,000 | -12.2% | 11,900 | -19.0% | 0.01% | -81.9% |
| Q4 2013 | $598,000 | -77.1% | 14,700 | -81.0% | 0.07% | +1.4% |
| Q3 2013 | $2,606,000 | +19.5% | 77,511 | +1.9% | 0.07% | +26.8% |
| Q2 2013 | $2,181,000 | – | 76,029 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |